Press Releases and Media Reports 2012

The Babraham Institute's External Relations Office is responsible for the communication strategy and corporate profile of the Babraham Group. The office facilitates communication with the media and promotes effective networking with the bioscience community and our stakeholders. All media enquiries should be made to the External Relations Office:

 

Dr Claire Cockcroft

Head of External Relations

Tel: +44 (0) 1223 496260

Email

 

 

The Babraham Institute announces collaboration with Karus Therapeutics to explore PI3 Kinase Inhibitors in the treatment of Inflammatory Diseases
December 2012

 

Crystal Bioscience and Open Monoclonal Technology announce Human Antibody Strategic Alliance
December 2012

 

Kymab to report Kymouse HK human antibody discovery data at the IBC Antibody Engineering Conference in San Diego, California
December 2012

 

Innova Biosciences appoints Dr Andrew Lane as an Executive Director and Tim Bernard as Chairman of the Board
December 2012

 

Bicycle Therapeutics announces £3.75 million financing for drug discovery
December 2012

 

Single Cell Technology and Open Monoclonal Technology Announce Human Antibody Discovery and Development Collaboration
December 2012

 

Atlantic Accelerator and DiagNodus speed development of cancer screening
November 2012

 

Imperial Innovations Group plc announces that portfolio company Veryan has received the CE Mark approval for BioMimics 3D™ Stent
November 2012

 

Antitope develops new biologic for treatment of multiple sclerosis
November 2012

 

Babraham Bioscience Technologies Announces that Cancer Research Technology (CRT) is to lease new chemistry facilities at the Babraham Research Campus
November 2012

 

ImmBio Wins Technology Strategy Board Award to develop a vaccine against invasive meningococcal disease
November 2012

 

Cambridge 'Fab Five' Share £39M BioMed Funding
November 2012

 

Babraham Research Campus, Neusentis (Pfizer) and Medimmune (AstraZeneca) announce initiative in open-innovation
October 2012

 

Ageing Research summit at Babraham explores the basic biology underpinning healthier lifespan
October 2012

 

Innova Biosciences signs out-licensing deal with StressMarq Biosciences
September 2012

 

Kymab Ltd - New antibody to revolutionise drug discovery
September 2012

 

Recombinant Antibody Technology ltd., part of OMT, was instrumental in producing human antibody repertoires in OmniRatsTM, part of the just announced new Antibody Discovery Program with Merck KGaA
September 2012

 

Eagle Genomics identifies key genome features which could lead to improved crops
July 2012

 

Population Genetics collaborates with Cambridge University to unravel the genetic causes of Asperger Syndrome
July 2012

 

Eagle and Rijk Zwaan accelerate plant trait prediction
July 2012

 

Innovations leads £22m funding round for PsiOxus Therapeutics
July 2012

 

Innovations leads $28m funding round for Oxford Immunotec
June 2012

 

Phico raises further £1m to develop E. coli fighting agent
June 2011

 

Population Genetics collaborate with University of Oxford
June 2012

 

Babraham's 9th Biotechnology Investment Forum facilitates finance opportunities for 18 companies
June 2012

 

Population Genetics collaborate with University of Oxford
June 2012

 

StemCells, Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration
June 2012

 

Almagen receives investment from IP Group plc and Providence Investment Company Ltd
May 2012

 

Taverna collaboration case study shows benefits of collaboration with Eagle Genomics
May 2012

F-star appoints new CEO, COO, and VP of Development and expands operations in Cambridge
May 2012

 

Antitope, Prothix, Bioceros, and University Medical Center Utrecht awarded Eurostars grant
May 2012

 

Innova Biosciences Secures Prestigious Development of Prototype Grant from the Technology Strategy Board.
May 2012

 

Proximagen notes positive vote from FDA advisory committee in respect of Arena’s 5-HT2c agonist lorcaserin
May 2012

 

StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial
May 2012

 

Minister opens new facilities to boost bioscience business at Babraham
May 2012

 

Unilever/Eagle case study published by Amazon
March 2012

 

StemCells to present at the Roth Growth OC Conference
March 2012

 

Latest Eagle brochures published
March 2012

 

First companies move in as Babraham Research Campus takes possession of latest Bioincubator
March 2012

 

Innova Biosciences Launches Unique Covalent Gold Nanoparticle Conjugation Kit
February 2012

 

Kymab Company Profile published by BioCentury©
February 2012

 

Proximagen Initiates PI Trial of Oral VAP-1 antagonist
February 2012

 

Senexis presents at CNS & Ageing Conference
February 2012

 

Andes Charity Challenge for Macmillan Cancer Support
January 2012

 

Babraham joins forces with The University of Cambridge's ideaSpace to accelerate enterprise
January 2012